France· FR:62373038
RETACNYL 0,025 %, crème
A medicinal product containing trétinoïne, registered in France by GALDERMA INTERNATIONAL.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TRÉTINOÏNE
- Manufacturer
- GALDERMA INTERNATIONAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009333443441 tube(s) aluminium verni de 30 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trétinoïne in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAltrenoBausch Health US, LLC
- United KingdomActicin 0.025% creamKyowa Kirin Ltd
- CanadaJAMP TRETINOINJAMP PHARMA CORPORATION
- FinlandAvitcidOrion Corporation
- NorwayCordes VASIchthyol-Gesellschaft
- SpainNEOCARE 4 mg/g CREMAIndustrial Farmaceutica Cantabria S.A.
- NetherlandsVesanoid, zachte capsules 10 mgCheplapharm Arzneimittel GmbH
- BelgiumTreclinax 10 mg/g - 0.25 mg/gViatris Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Vesanoid
- Belgium · Vesanoid
- Germany · Cordes Vas, Vesanoid
- Spain · Neocare, Retirides
- Finland · Avitcid, Vesanoid
- United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
- Croatia · Vesanoid
- Ireland · Vesanoid
- Italy · Tretinoina Same Savoma Medicinali, Vesanoid
- Malta · Ketrel
- Netherlands · Vesanoid
- Poland · Vesanoid
- Portugal · Ketrel, Vesanoid
- Slovakia · Vesanoid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab6228ef-8d4e-4bb7-9382-7bd8c9ba1a42 GET /v1/drugs/ab6228ef-8d4e-4bb7-9382-7bd8c9ba1a42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62373038",
"date_amm": "1991-01-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TRÉTINOÏNE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "crème",
"voies_administration": "cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about trétinoïne.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.